Phase I is a moratorium on all federal rulemaking until June 30. Phase II is legislation to change the regulatory process itself. This "risk bill" introduced would require regulatory agencies to conduct a risk assessment for any proposed new regulations. Any regulation that would cost more than $25 million in compliance costs also would require a cost-benefit analysis. Regulations whose costs outweighed benefits would be withdrawn. According to McIntosh, Phase III would require federal agencies to review and revise existing regulations to make it easier for the business community to operate.
Deregulation would affect packaging industry
Efforts by Congress to ease the federal regulatory burdens on business could have a big impact on all aspects of the packaging industry. Rep. David McIntosh (R-IN), a leader in the deregulation efforts, outlined a three-phase process.
Feb 28, 1995
Machinery Basics
Pharmaceutical Innovations Report
Discover the latest breakthrough packaging technologies shaping the pharmaceutical sector. This report dives into cutting-edge innovations, from smart containers that enhance patient safety to eco-friendly materials poised to transform the industry’s sustainability practices. All from PACK EXPO. Learn how forward-thinking strategies are driving efficiency and redefining what’s possible in pharma packaging.
Learn More
Smart Filling Equipment Selection Guide
Discover the six critical factors that determine filling equipment success and avoid costly selection mistakes that drain profits.
Read More
